跳至主要内容
临床试验/NCT04217161
NCT04217161进行中(未招募)不适用

Comparison of Dexcom G6 Continuous Glucose Monitoring System and Blood Glucose Levels in Adult Hemodialysis Patients With Diabetes

University of California, Irvine2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
30
试验地点
2
主要终点
Blood glucose measurement

研究概览

简要总结

This is a pilot study enrolling adult hemodialysis patients with diabetes recruited from the University of California Irvine Medical Center (UCIMC) who will undergo simultaneous measurement of glucose levels using 1) continuous glucose monitor (CGM) measured by a Dexcom G6 device vs. 2) "gold-standard" blood glucose levels using capillary fingerstick or venous blood glucose measurements obtained on a point of care (POC) blood glucose meter. The study will assess Dexcom G6 accuracy by comparing glucose levels on the CGM device vs. blood glucose measurements in the study population.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult hemodialysis patients age 18 years or older
  • Have a comorbidity of diabetes
  • Receipt of care from the inpatient University of California Irvine Medical Center nephrology consult service
  • Expected hospital stay ≥48 hours
  • Have the ability to directly provide informed consent for participation in the study

排除标准

  • Critically-ill patients receiving care in the intensive care unit (ICU) or cardiac care unit (CCU)
  • Moribund patients expected to die within 48 hours
  • Presence of any condition deemed by PI's judgment that would seriously limit life expectancy (i.e., poor survival)
  • Unwilling or unable to provide informed consent

结局指标

主要结局

Blood glucose measurement

时间窗: 3 to 5 days

Proportion of CGM values within 20% of blood glucose levels \>100 mg/dl or within 20 mg/dl of blood glucose level for levels \<=100 mg/dl. (Will examine different thresholds of CGM values within a certain range of blood glucose levels, i.e., 10%, 15%, 25%.)

次要结局

  • Hypoglycemia events(3 to 5 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Connie Rhee

Assistant Professor of Medicine

University of California, Irvine

研究点 (2)

Loading locations...

相似试验